(Q42670445)
Statements
Safety and antiviral response at 12 months of lopinavir/ritonavir therapy in human immunodeficiency virus-1-infected children experienced with three classes of antiretrovirals (English)
María Angeles Muñoz-Fernández
José T Ramos
María Isabel De José
Joaquín Dueñas
Claudia Fortuny
Raúl González-Montero
María José Mellado
Marisa Navarro
Carmen Otero
Itziar Pocheville
Esther Cabrero
Spanish Collaborative Group on HIV Infection in Children